top of page

BackTable / Urology / Podcast / Episode #204

Managing Low & Intermediate RIsk Bladder Cancer

with Dr. Betsy Koehne and Dr. Amir Salmasi

Stay up to date in your bladder cancer practice with this insightful episode of the BackTable Urology podcast, developed in collaboration with the Society of Urologic Oncology. Dr. Betsy Koehne (University of Wisconsin) and Dr. Amir Salmasi (UC San Diego) talk through the contemporary management of low and intermediate-risk non-muscle-invasive bladder cancer.

This podcast was developed in collaboration with:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Managing Low & Intermediate RIsk Bladder Cancer with Dr. Betsy Koehne and Dr. Amir Salmasi on the BackTable Urology Podcast)
Ep 204 Managing Low & Intermediate RIsk Bladder Cancer with Dr. Betsy Koehne and Dr. Amir Salmasi
00:00 / 01:04

BackTable, LLC (Producer). (2024, December 6). Ep. 204 – Managing Low & Intermediate RIsk Bladder Cancer [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Elizabeth Koehne discusses Managing Low & Intermediate RIsk Bladder Cancer on the BackTable 204 Podcast

Dr. Elizabeth Koehne

Dr. Betsy Koehne is a urologist at the University of WIsconsin-Madison School of Medicine in Madison, Wisconisin.

Dr. Amir Salmasi discusses Managing Low & Intermediate RIsk Bladder Cancer on the BackTable 204 Podcast

Dr. Amir Salmasi

Dr. Amir Salmasi is a urologist at UC Sand Diego Health in San Diego, California.

Dr. Aditya Bagrodia discusses Managing Low & Intermediate RIsk Bladder Cancer on the BackTable 204 Podcast

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Synopsis

The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments.

Timestamps

00:00 - Introduction
01:51 - Initial Consultation
08:01 - TURBT Procedure Insights
23:14 - Managing Low and Intermediate Risk Bladder Cancer
26:47 - Recurrence and Surveillance Strategies
27:48 - Prognostication Tools
30:10 - Intravesical Chemotherapy Options
33:24 - High Grade Tumors
42:33 - Clinical Trials and Emerging Therapies
49:19 - Concluding Thoughts

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast)
Active Surveillance: A Data-Driven Approach with Dr. Dan Lin on the BackTable Urology Podcast)
Expert Approaches to Complex PC RPLND Cases Part 2 with Dr. Timothy Masterson and Dr. Rob Hamilton on the BackTable Urology Podcast)
Expert Approaches to Complex PC RPLND Cases Part 1 with Dr. Timothy Masterson and Dr. Rob Hamilton on the BackTable Urology Podcast)
Managing Biochemical Recurrence After Prostate Radiation  with Dr. Amar Kishan on the BackTable Urology Podcast)
Perfecting Rectal Spacer Placement for Optimal Care with Dr. Neil Taunk on the BackTable Urology Podcast)

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

bottom of page